Identification of novel chromosomal rearrangements in acute myelogenous leukemia involving loci on chromosome 2p23, 15q22 and 17q21

Leukemia

Volumn 13, Issue 10, 1999, Pages 1534-1538

  Melnick, A ^a   Fruchtman, S ^a   Zelent, A ^b   Liu, M ^b   Huang, Q ^b   Boczkowska, B ^a   Calasanz, M J ^b   Fernandez, A ^b   Licht, J D ^a   Najfeld, V ^a  

^a MOUNT SINAI MEDICAL CENTER   (United States)

^b NONE

Author keywords

Acute myelogenous leukemia; Cytogenetics; Fluorescent; In situ hybridization; Translocation; Tumor genetics

Indexed keywords

CYTARABINE; IDARUBICIN;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ARTICLE; CASE REPORT; CHROMOSOME 15Q; CHROMOSOME 17Q; CHROMOSOME 2P; CHROMOSOME TRANSLOCATION 15; CHROMOSOME TRANSLOCATION 17; CHROMOSOME TRANSLOCATION 2; FLUORESCENCE IN SITU HYBRIDIZATION; GENE EXPRESSION REGULATION; GENE TRANSFER; HUMAN; HUMAN CELL; KARYOTYPE; MALE; MONOCYTIC LEUKEMIA; MYELOID LEUKEMIA; PRIORITY JOURNAL;

EID: 0032830033     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2401513     Document Type: Article

References (51)

1. Miyoshi H, Kozu T, Shimizu K, Enomoto K, Maseki N, Kaneko Y, Kamada N, Ohki M. The t(8;21) translocation in acute myeloid leukemia results in production of an AML1-MTG8 fusion transcript. EMBO J 1993; 12: 2715-2721.
2. Nucifora G, Rowley JD. The AML1 and ETO genes in acute myeloid leukemia with a t(8;21). Leuk Lymphoma 1994; 14: 353-362.
3. Buchner T, Heinecke A. The role of prognostic factors in acute myeloid leukemia. Leukemia 1996; 10 (Suppl. 1): S28-29.
4. Melnick A, Licht JD. Deconstructing a disease: RARalpha, its fusion partners, and their roles in the pathogenesis of acute promyelocytic leukemia. Blood 1999; 93: 3167-3215.
5. Coyle T, Najfeld V. Translocation (3;21) in Philadelphia chromosome-positive chronic myelogenous leukemia prior to the onset of blast crisis. Am J Hematol 1988; 27: 56-59.
6. Mitelman F. An International System for Human Cytogenetic Nomenclature. S Karger: Basel, 1995.
7. Mattei MG, Petkovich M, Mattei JF, Brand N, Chambon P. Mapping of the human retinoic acid receptor to the q21 band of chromosome 17. Hum Genet 1988; 80: 186-188.
8. Tsai S, Collins SJ. A dominant negative retinoic acid receptor blocks neutrophil differentiation at the promyelocyte stage. Proc Natl Acad Sci USA 1993; 90: 7153-7157.
9. Blackwood MA, Weber BL. BRCA1 and BRCA2: from molecular genetics to clinical medicine. J Clin Oncol 1998; 16: 1969-1977.
10. Scully R, Chen J, Plug A, Xiao Y, Weaver D, Feunteun J, Ashley T, Livingston DM. Association of BRCA1 with Rad51 in mitotic and meiotic cells. Cell 1997; 88: 265-275.
11. Somasundaram K, Zhang H, Zeng YX, Houvras Y, Peng Y, Zhang H, Wu GS, Licht JD, Weber BL, El-Deiry WS. Arrest of the cell cycle by the tumour-suppressor BRCA1 requires the CDK-inhibitor p21WAF1/CiP1. Nature 1997; 389: 187-190.
12. OMIM. Online Mendelian Inheritance in Man. http://www.ncbi.nlm.nih.gov/Omim 1999.
13. Magli MC, Largman C, Lawrence HJ. Effects of HOX homeobox genes in blood cell differentiation. J Cell Physiol 1997; 173: 168-177.
14. Carter KC, Wang L, Shell BK, Zamir I, Berger SL, Moore PA. The human transcriptional adaptor genes TADA2L and GCN5L2 colocalize to chromosome 17q12-q21 and display a similar tissue expression pattern. Genomics 1997; 40: 497-500.
15. Struhl K, Moqtaderi Z. The TAFs in the HAT. Cell 1998; 94: 1-4.
16. Kitabayashi I, Yokoyama A, Shimizu K, Ohki M. Interaction and functional cooperation of the leukemia-associated factors AML1 and p300 in myeloid cell differentiation. EMBO J 1998; 17: 2994-3004.
17. Lutterbach B, Westendorf JJ, Linggi B, Patten A, Moniwa M, Davie JR, Huynh KD, Bardwell VJ, Lavinsky RM, Rosenfeld MG, Galss C, Seto E, Hiebert SW. ETO, a target of t(8;21) in acute leukemia, interacts with the N-CoR and mSin3 corepressors. Mol Cell Biol 1998; 18: 7176-7184.
18. Isobe M, Yamagishi F, Yoshida K, Higashino F, Fujinaga K. Assignment of the ets-related transcription factor E1A-F gene (ETV4) to human chromosome region 17q21. Genomics 1995; 28: 357-359.
19. Higashino F, Yoshida K, Noumi T, Seiki M, Fujinaga K. Ets-related protein E1A-F can activate three different matrix metalloproteinase gene promoters. Oncogene 1995; 10: 1461-1463.
20. Hida K, Shindoh M, Yoshida K, Kudoh A, Furaoka K, Kohgo T, Fujinaga K, Totsuka Y. Expression of E1AF, an ets-family transcription factor, is correlated with the invasive phenotype of oral squamous cell carcinoma. Oral Oncol 1997; 33: 426-430.
21. Hida K, Shindoh M, Yasuda M, Hanzawa M, Funaoka K, Kohgo T, Amemiya A, Totsuka Y, Yoshida K, Fujinaga K. Antisense E1AF transfection restrains oral cancer invasion by reducing matrix metalloproteinase activities. Am J Pathol 1997; 150: 2125-2132.
22. Taguchi K, Yoshida K, Sasaki F, Fujinaga K. Two transcription factors, E1AF and N-myc, correlate with the invasiveness of neuroblastoma cell lines. Jpn J Cancer Res 1997; 88: 394-400.
23. Shindoh M, Higashino F, Kaya M, Yasuda M, Funaoka K, Hanzawa M, Hida K, Kohgo T, Amemiya A, Yoshida K, Fujinaga K. Correlated expression of matrix metalloproteinases and ets family transcription factor E1A-F in invasive oral squamous-cell-carcinoma-derived cell lines. Am J Pathol 1996; 148: 693-700.
24. Urano F, Umezawa A, Hong W, Kikuchi H, Hata J. A novel chimera gene between EWS and E1A-F, encoding the adenovirus E1A enhancer-binding protein, in extraosseous Ewing's sarcoma. Biochem Biophys Res Commun 1996; 219: 608-612.
25. Kaneko Y, Yoshida K, Handa M, Toyoda Y, Nishihira H, Tanaka Y, Sasaki Y, Ishida S, Higashino F, Fujinaga K. Fusion of an ETS-family gene, EIAF, to EWS by t(17;22)(q12;q12) chromosome translocation in an undifferentiated sarcoma of infancy. Genes Chromosomes Cancer 1996; 15: 115-121.
26. Williams RS, Shohet RV, Stillman B. A human protein related to yeast Cdc6p. Proc Natl Acad Sci USA 1997; 94: 142-147.
27. Yan Z, DeGregori J, Shohet R, Leone G, Stillman B, Nevins JR, Williams RS. Cdc6 is regulated by E2F and is essential for DNA replication in mammalian cells. Proc Natl Acad Sci USA 1998; 95: 3603-3608.
28. Borden K, Campbelldwyer E, Carlile G, Djavani M, Salvato M. Two RING finger proteins, the oncoprotein PML and the arena-virus Z protein, colocalize with the nuclear fraction of the ribosomal P proteins. J Virol 1998; 72: 3819-3826.
29. Wang ZG, Delva L, Gaboli M, Rivi R, Giorgio M, Cordon-Cardo C, Grosveld F, Pandolfi PP. Role of PML in cell growth and the retinoic acid pathway. Science 1998; 279: 1547-1551.
30. Rampoldi L, Zimbello R, Bortoluzzi S, Tiso N, Valle G, Lanfranchi G, Danieli GA. Chromosomal localization of four MARK signaling cascade genes: MEK1, MEK3, MEK4 and MEKK5. Cytogenet Cell Genet 1997; 78: 301-303.
31. Brunet A, Pages G, Pouyssegur J. Constitutively active mutants of MAP kinase kinase (MEK1) induce growth factor-relaxation and oncogenicity when expressed in fibroblasts. Oncogene 1994; 9: 3379-3387.
32. Greulich H, Erikson RL. An analysis of Mek1 signaling in cell proliferation and transformation. J Biol Chem 1998; 273: 13280-13288.
33. Seger R, Krebs EG. The MAPK signaling cascade. FASEB J 1995; 9: 726-735.
34. Liu Y, Dehni G, Purcell KJ, Sokolow J, Carcangiu ML, Artavanis-Tsakonas S, Stifani S. Epithelial expression and chromosomal location of human TLE genes: implications for notch signaling and neoplasia. Genomics 1996; 31: 58-64.
35. Ellisen LW, Bird J, West DC, Soreng AL, Reynolds TC, Smith SD, Sklar J. TAN-1, the human homolog of the Drosophila notch gene, is broken by chromosomal translocations in T lymphoblastic neoplasms. Cell 1991; 66: 649-661.
36. Yavari R, Adida C, Bray-Ward P, Brines M, Xu T. Human metalloprotease-disintegrin Kuzbanian regulates sympathoadrenal cell fate in development and neoplasia. Hum Mol Genet 1998; 7: 1161-1167.
37. Qi H, Rand MD, Wu X, Sestan N, Wang W, Rakic P, Xu T, Artavanis-Tsakonas S. Processing of the notch ligand delta by the metalloprotease Kuzbanian. Science 1999; 283: 91-94.
38. Wang JY, Zhen DK, Blanchi DW, Androphy EJ, Chen JJ. Assignment of the gene for ERC-55 (RCN2) to human chromosome band 15q22.33 → q24.1 by in situ hybridization. Cytogenet Cell Genet 1997; 79: 60-61.
39. Chen JJ, Reid CE, Band V, Androphy EJ. Interaction of papillomavirus E6 oncoproteins with a putative calcium-binding protein. Science 1995; 269: 529-531.
40. Farag S, Challis J, White J, Garson OM. Novel translocation (2;4) with consistent involvement of 2p23 in acute nonlymphocytic leukemia (M2). Cancer Genet Cytogenet 1992; 58: 48-51.
41. Shi G, Weh HJ, Hossfeld DK. Translocation (2;4)(p23;q25): an additional case of a new recurrent anomaly in acute myeloid leukemia. Cancer Genet Cytogenet 1993; 70: 140-141.
42. Richkind KE, Lamb A, Lytle C, Velasco J. A third case of apparent t(2;4)(p23;q25) represents ins(2;4) with deletion of 2p. Leukemia 1996; 10: 1847.
43. Levaltier X, Penther D, Bastard C, Troussard X. t(2;3)(p23;q26) in a patient with AML M2. Br J Haematol 1996; 92: 1027.
44. Sato H, Saito H, Ikebuchi K, Danbara M, Yagisawa M, Yuo A. Biological characteristics of chronic eosinophilic leukemia cells with a t(2;5)(p23;q35) translocation. Leuk Lymphoma 1995; 19: 499-505.
45. Ferro T, Krsnik I, Resino M, Cabello P, Garcia-Sagredo JM, San Roman C. Deletion(2)(p23) abnormality in a case of secondary acute myeloid leukemia. Cancer Genet Cytogenet 1993; 66: 126-127.
46. Verma RS, Macera MJ, da Costa M, Bradley T, Christodoulidou F. del(2)(p23): a consistent recurrent abnormality in acute myelogenous leukemia. Cancer Genet Cytogenet 1991; 57: 175-179.
47. Najfeld V, Scalise A, Fruchtman S, Troy K. del(2)(p23): a new recurrent abnormality in acute myeloid leukemia. Cancer Genet Cytogenet 1990; 46: 185-190.
48. Morris SW, Kirstein MN, Valentine MB, Dittmer K, Shapiro DN, Look AT, Saltman DL. Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma. Science 1995; 267: 316-317.
49. Molven A, Houge G, Berger R. Chromosomal assignment of the human gene encoding the Fos-related antigen-2 (FRA2) to chromosome 2p22-p23. Genomics 1996; 38: 72-75.
50. Liebermann DA, Hoffman B. Differentiation primary response genes and proto-oncogenes as positive and negative regulators of terminal hematopoietic cell differentiation. Stem Cells (Dayt) 1994; 12: 352-369.
51. Look AT. Genes altered by chromosomal translocations in leukemias and lymphomas. In: Vogelstein B, Kinzler KW (eds). The Genetic Basis of Human Cancer. McGraw-Hill: New York, 1998, pp 109-142.